Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | PTEN |
Variant | V275* |
Impact List | nonsense |
Protein Effect | loss of function - predicted |
Gene Variant Descriptions | PTEN V275* results in a premature truncation of the Pten protein at amino acid 275 of 403 (UniProt.org). V275* results in reduced phosphatase activity in a yeast assay (PMID: 29706350), and therefore, is predicted to lead to a loss of Pten protein function. |
Associated Drug Resistance | |
Category Variants Paths |
PTEN mutant PTEN inact mut PTEN V275* |
Transcript | NM_000314.8 |
gDNA | chr10:g.87960915_87960916delGTinsTA |
cDNA | c.823_824delGTinsTA |
Protein | p.V275* |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_000314 | chr10:g.87960915_87960916delGTinsTA | c.823_824delGTinsTA | p.V275* | RefSeq | GRCh38/hg38 |
NM_000314.6 | chr10:g.87960915_87960916delGTinsTA | c.823_824delGTinsTA | p.V275* | RefSeq | GRCh38/hg38 |
NM_000314.8 | chr10:g.87960915_87960916delGTinsTA | c.823_824delGTinsTA | p.V275* | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|---|---|---|---|---|---|---|
PTEN V275* | triple-receptor negative breast cancer | sensitive | DHM25 | Preclinical - Cell culture | Actionable | In a preclinical study, DHM25 increased cell death and decreased migration of a triple-negative breast cancer cell line harboring PTEN V275* in culture (PMID: 26237138). | 26237138 |